Improvement of physical and mental health of patients with parathyroid hypofunction

The present application relates to a sustained release PTH compound useful in a method of improving and treating physical and mental health in patients with hypoparathyroidism, wherein the sustained release PTH compound releases PTH with a release half-life of at least 12 hours. In another aspect, t...

Full description

Saved in:
Bibliographic Details
Main Author SPROGOE KENNETT
Format Patent
LanguageChinese
English
Published 03.10.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present application relates to a sustained release PTH compound useful in a method of improving and treating physical and mental health in patients with hypoparathyroidism, wherein the sustained release PTH compound releases PTH with a release half-life of at least 12 hours. In another aspect, the present application relates to a method of improving physical and mental health in a patient suffering from parathyroid hypofunction comprising administering to the patient a sustained-release PTH compound wherein the sustained-release PTH compound releases PTH with a release half-life of at least 12 hours, thereby improving the physical and mental health in the patient. 本申请涉及一种在改善和治疗甲状旁腺功能减退症患者的身体及心理健康的方法中可用的缓释PTH化合物，其中所述缓释PTH化合物以至少12小时的释放半衰期释放PTH。在另一个方面，本申请涉及一种改善患有甲状旁腺功能减退症患者的身体及心理健康的方法，包括给患者施用缓释PTH化合物，其中所述缓释PTH化合物以至少12小时的释放半衰期释放PTH，从而改善患者的身体及心理健康。
Bibliography:Application Number: CN202180079181